Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyramidal Cells | 3 | 2019 | 35 | 1.200 |
Why?
|
| alpha-Synuclein | 4 | 2014 | 117 | 1.130 |
Why?
|
| Prefrontal Cortex | 3 | 2019 | 128 | 1.120 |
Why?
|
| Calcium Channels, L-Type | 2 | 2017 | 46 | 1.040 |
Why?
|
| Dopamine | 5 | 2014 | 82 | 0.870 |
Why?
|
| Substantia Nigra | 2 | 2014 | 115 | 0.760 |
Why?
|
| HIV-1 | 3 | 2019 | 204 | 0.700 |
Why?
|
| Dependovirus | 3 | 2014 | 39 | 0.550 |
Why?
|
| AIDS Dementia Complex | 1 | 2017 | 39 | 0.540 |
Why?
|
| Genetic Vectors | 3 | 2014 | 55 | 0.540 |
Why?
|
| Neurons | 4 | 2014 | 326 | 0.510 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 26 | 0.500 |
Why?
|
| MicroRNAs | 2 | 2014 | 42 | 0.500 |
Why?
|
| Corpus Striatum | 2 | 2014 | 65 | 0.480 |
Why?
|
| Animals | 10 | 2019 | 3330 | 0.470 |
Why?
|
| Calcium | 1 | 2017 | 334 | 0.460 |
Why?
|
| Gene Silencing | 2 | 2011 | 21 | 0.450 |
Why?
|
| Rats | 6 | 2019 | 609 | 0.440 |
Why?
|
| RNA Interference | 1 | 2014 | 35 | 0.430 |
Why?
|
| Genetic Therapy | 2 | 2012 | 84 | 0.430 |
Why?
|
| Dwarfism | 2 | 2010 | 2 | 0.420 |
Why?
|
| Aging | 3 | 2019 | 1460 | 0.390 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 4 | 0.390 |
Why?
|
| Nerve Degeneration | 1 | 2012 | 47 | 0.380 |
Why?
|
| Hypothalamus | 2 | 2010 | 13 | 0.370 |
Why?
|
| Dopaminergic Neurons | 1 | 2012 | 47 | 0.360 |
Why?
|
| Growth Hormone | 1 | 2010 | 1 | 0.340 |
Why?
|
| Parkinsonian Disorders | 1 | 2011 | 205 | 0.290 |
Why?
|
| Dwarfism, Pituitary | 1 | 2007 | 1 | 0.290 |
Why?
|
| Prolactin | 1 | 2007 | 4 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2014 | 312 | 0.280 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 560 | 0.270 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2014 | 52 | 0.260 |
Why?
|
| Male | 9 | 2019 | 13669 | 0.260 |
Why?
|
| HIV Infections | 2 | 2019 | 433 | 0.210 |
Why?
|
| Forelimb | 2 | 2014 | 5 | 0.200 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 75 | 0.190 |
Why?
|
| Action Potentials | 2 | 2019 | 79 | 0.170 |
Why?
|
| Membrane Potentials | 2 | 2018 | 127 | 0.160 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2019 | 4 | 0.160 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2019 | 6 | 0.160 |
Why?
|
| Potassium Channels | 1 | 2018 | 23 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 24 | 0.150 |
Why?
|
| Body Weight | 2 | 2010 | 128 | 0.150 |
Why?
|
| Methamphetamine | 1 | 2018 | 22 | 0.150 |
Why?
|
| Mice | 4 | 2011 | 1296 | 0.150 |
Why?
|
| Rats, Transgenic | 1 | 2017 | 18 | 0.140 |
Why?
|
| Astrocytes | 1 | 2018 | 138 | 0.130 |
Why?
|
| Gene Expression | 1 | 2017 | 196 | 0.130 |
Why?
|
| Signal Transduction | 1 | 2018 | 413 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 72 | 0.130 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 210 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2011 | 56 | 0.110 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2014 | 2 | 0.110 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 29 | 0.110 |
Why?
|
| Movement Disorders | 1 | 2014 | 66 | 0.100 |
Why?
|
| Humans | 5 | 2018 | 24703 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2012 | 129 | 0.090 |
Why?
|
| Neural Pathways | 1 | 2012 | 61 | 0.090 |
Why?
|
| Motor Activity | 1 | 2014 | 308 | 0.090 |
Why?
|
| Catecholamines | 1 | 2010 | 6 | 0.080 |
Why?
|
| Swine | 1 | 2010 | 63 | 0.080 |
Why?
|
| Diquat | 1 | 2009 | 1 | 0.080 |
Why?
|
| Paraquat | 1 | 2009 | 2 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 348 | 0.080 |
Why?
|
| Longevity | 1 | 2009 | 29 | 0.080 |
Why?
|
| Genotype | 1 | 2010 | 332 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2009 | 94 | 0.080 |
Why?
|
| Sex Factors | 1 | 2010 | 443 | 0.080 |
Why?
|
| Parkinson Disease | 2 | 2012 | 633 | 0.070 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 9 | 0.070 |
Why?
|
| Pituitary Gland | 1 | 2007 | 14 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2007 | 129 | 0.070 |
Why?
|
| Time Factors | 1 | 2010 | 1327 | 0.060 |
Why?
|
| Female | 3 | 2010 | 14048 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2011 | 3208 | 0.050 |
Why?
|
| Fetus | 1 | 2018 | 34 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2018 | 39 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2019 | 294 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2018 | 492 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2011 | 2 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 40 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 228 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2009 | 6 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2009 | 14 | 0.020 |
Why?
|
| Exercise Test | 1 | 2009 | 57 | 0.020 |
Why?
|
| Liver | 1 | 2009 | 142 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 398 | 0.020 |
Why?
|